Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sampram, ESK; Lindblad, B
   The impact of Factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions
   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
   
   E.S.K. Sampram e B. Lindblad, "The impact of Factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions", EUR J VAS E, 22(2), 2001, pp. 134-138
2. Dragoni, F; Tormene, D; Simioni, P; Arcieri, P; Avvisati, G; Girolami, A
   ProC global: A new automated screening assay for the evaluation of total function of the protein C system
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   F. Dragoni et al., "ProC global: A new automated screening assay for the evaluation of total function of the protein C system", CL APPL T-H, 7(4), 2001, pp. 351-355
3. Mira, Y; Todoli, J; Alonso, R; Mico, ML; Vaya, A; Ferrando, F; Estelles, A; Villa, P; Aznar, J
   Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   Y. Mira et al., "Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases", CL APPL T-H, 7(3), 2001, pp. 234-237
4. Linfert, DR; Tsongalis, GJ
   Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphisms
   DIAGNOSTIC MOLECULAR PATHOLOGY
   
   D.R. Linfert e G.J. Tsongalis, "Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphisms", DIAGN MOL P, 10(2), 2001, pp. 111-115
5. Olah, L; Misz, M; Kappelmayer, J; Ajzner, E; Csepany, T; Fekete, I; Bereczki, D; Blasko, G; Csiba, L
   Natural coagulation inhibitor proteins in young patients with cerebral ischemia
   CEREBROVASCULAR DISEASES
   
   L. Olah et al., "Natural coagulation inhibitor proteins in young patients with cerebral ischemia", CEREB DIS, 12(4), 2001, pp. 291-297
6. Quincampoix, JC; Legarff, M; Rittling, C; Andiva, S; Toulon, P
   Modification of the ProC (R) Global assay using dilution of patient plasmain factor V-depleted plasma as a screening assay for factor V Leiden mutation
   BLOOD COAGULATION & FIBRINOLYSIS
   
   J.C. Quincampoix et al., "Modification of the ProC (R) Global assay using dilution of patient plasmain factor V-depleted plasma as a screening assay for factor V Leiden mutation", BL COAG FIB, 12(7), 2001, pp. 569-576
7. Kayiran, SM; Ozbek, N; Caner, H; Tokel, KA; Mercan, S; Alehan, F
   Activated protein C resistance and false type 2 protein C deficiency detected after multiple shunt failures in a patient with hydrocephalus
   JOURNAL OF CHILD NEUROLOGY
   
   S.M. Kayiran et al., "Activated protein C resistance and false type 2 protein C deficiency detected after multiple shunt failures in a patient with hydrocephalus", J CHILD NEU, 16(11), 2001, pp. 862-863
8. Incorvaia, C; Parmeggiani, F; Costagliola, C; Lamberti, G; Ferraresi, P; Bernardi, F; Sebastiani, A
   The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study
   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
   
   C. Incorvaia et al., "The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study", GR ARCH CL, 239(4), 2001, pp. 251-256
9. Robetorye, RS; Rodgers, GM
   Update on selected inherited venous thrombotic disorders
   AMERICAN JOURNAL OF HEMATOLOGY
   
   R.S. Robetorye e G.M. Rodgers, "Update on selected inherited venous thrombotic disorders", AM J HEMAT, 68(4), 2001, pp. 256-268
10. Emmerich, J; Rosendaal, FR; Cattaneo, M; Margaglione, M; De Stefano, V; Cumming, T; Arruda, V; Hillarp, A; Reny, JL
    Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including2310 cases and 3204 controls
    THROMBOSIS AND HAEMOSTASIS
    
    J. Emmerich et al., "Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including2310 cases and 3204 controls", THROMB HAEM, 86(3), 2001, pp. 809-816
11. Martinelli, I
    Risk factors in venous thromboembolism
    THROMBOSIS AND HAEMOSTASIS
    
    I. Martinelli, "Risk factors in venous thromboembolism", THROMB HAEM, 86(1), 2001, pp. 395-403
12. Heit, JA; Silverstein, MD; Mohr, DN; Petterson, TM; Lohse, CM; O'Fallon, WM; Melton, LJ
    The epidemiology of venous thromboembolism in the community
    THROMBOSIS AND HAEMOSTASIS
    
    J.A. Heit et al., "The epidemiology of venous thromboembolism in the community", THROMB HAEM, 86(1), 2001, pp. 452-463
13. de Visser, MCH; Poort, SR; Vos, HL; Rosendaal, FR; Bertina, RM
    Factor X levels, polymorphisms in the promoter region of factor X, and therisk of venous thrombosis
    THROMBOSIS AND HAEMOSTASIS
    
    M.C.H. de Visser et al., "Factor X levels, polymorphisms in the promoter region of factor X, and therisk of venous thrombosis", THROMB HAEM, 85(6), 2001, pp. 1011-1017
14. Shen, MC; Lin, JS; Tsay, W
    Factor V Arg(306)-> Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese
    THROMBOSIS AND HAEMOSTASIS
    
    M.C. Shen et al., "Factor V Arg(306)-> Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese", THROMB HAEM, 85(2), 2001, pp. 270-273
15. Hoekema, L; Castoldi, E; Tans, G; Girelli, D; Gemmati, D; Bernardi, F; Rosing, J
    Functional properties of factor V and factor Va encoded by the R2-gene
    THROMBOSIS AND HAEMOSTASIS
    
    L. Hoekema et al., "Functional properties of factor V and factor Va encoded by the R2-gene", THROMB HAEM, 85(1), 2001, pp. 75-81
16. Rosing, J; Curvers, J; Tans, G
    Oral contraceptives, thrombosis and haemostasis
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    
    J. Rosing et al., "Oral contraceptives, thrombosis and haemostasis", EUR J OB GY, 95(2), 2001, pp. 193-197
17. Bozzo, M; Carpani, G; Leo, L; Marcozzi, S; Sacchi, E; Moroni, G; Pardi, G
    HELLP syndrome and factor V Leiden
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    
    M. Bozzo et al., "HELLP syndrome and factor V Leiden", EUR J OB GY, 95(1), 2001, pp. 55-58
18. Linden, MD; Schneider, M; Erber, WN
    Factor V-LEIDEN and cardiopulmonary bypass: investigation of haemostatic parameters and the effect of aprotinin using an ex vivo model
    PERFUSION-UK
    
    M.D. Linden et al., "Factor V-LEIDEN and cardiopulmonary bypass: investigation of haemostatic parameters and the effect of aprotinin using an ex vivo model", PERFUSION-U, 16(6), 2001, pp. 476-484
19. Toulon, P; Adda, R; Perez, P
    Sensitivity of the ProC((R)) global assay for protein C pathway abnormalities. Clinical experience in 899 unselected patients with venous thromboembolism
    THROMBOSIS RESEARCH
    
    P. Toulon et al., "Sensitivity of the ProC((R)) global assay for protein C pathway abnormalities. Clinical experience in 899 unselected patients with venous thromboembolism", THROMB RES, 104(2), 2001, pp. 93-103
20. Nowak-Gottl, U; Kotthoff, S; Hagemeyer, E; Junker, R; Kehl, HG; Vielhaber, H; Kececioglu, D
    Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease - A prospective study
    THROMBOSIS RESEARCH
    
    U. Nowak-Gottl et al., "Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease - A prospective study", THROMB RES, 103(2), 2001, pp. 93-101
21. Eldridge, J; Dilley, A; Austin, H; EL-Jamil, M; Wolstein, L; Doris, J; Hooper, WC; Meehan, PL; Evatt, B
    The role of protein C, protein S, and resistance to activated protein C inLegg-Perthes disease
    PEDIATRICS
    
    J. Eldridge et al., "The role of protein C, protein S, and resistance to activated protein C inLegg-Perthes disease", PEDIATRICS, 107(6), 2001, pp. 1329-1334
22. Hademenos, GJ; Alberts, MJ; Awad, I; Mayberg, M; Shephard, T; Jagoda, A; Latchaw, RE; Todd, HW; Viste, K; Starke, R; Girgus, MS; Walker, M; Marler, J; Emr, M; Hart, N
    Advances in the genetics of cerebrovascular disease and stroke
    NEUROLOGY
    
    G.J. Hademenos et al., "Advances in the genetics of cerebrovascular disease and stroke", NEUROLOGY, 56(8), 2001, pp. 997-1008
23. Hoibraaten, E; Mowinckel, MC; de Ronde, H; Bertina, RM; Sandset, PM
    Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial
    BRITISH JOURNAL OF HAEMATOLOGY
    
    E. Hoibraaten et al., "Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial", BR J HAEM, 115(2), 2001, pp. 415-420
24. Walker, ID; Greaves, M; Preston, FE
    Investigation and management of heritable thrombophilia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    I.D. Walker et al., "Investigation and management of heritable thrombophilia", BR J HAEM, 114(3), 2001, pp. 512-528
25. Mannucci, PM
    Genetic hypercoagulability: prevention suggests testing family members
    BLOOD
    
    P.M. Mannucci, "Genetic hypercoagulability: prevention suggests testing family members", BLOOD, 98(1), 2001, pp. 21-22
26. Federman, DG; Kirsner, RS
    An update on hypercoagulable disorders
    ARCHIVES OF INTERNAL MEDICINE
    
    D.G. Federman e R.S. Kirsner, "An update on hypercoagulable disorders", ARCH IN MED, 161(8), 2001, pp. 1051-1056
27. Bauer, KA
    The thrombophilias: Well-defined risk factors with uncertain therapeutic implications
    ANNALS OF INTERNAL MEDICINE
    
    K.A. Bauer, "The thrombophilias: Well-defined risk factors with uncertain therapeutic implications", ANN INT MED, 135(5), 2001, pp. 367-373
28. Gouin-Thibault, I; Achkar, A; Samama, MM
    The thrombophilic state in cancer patients
    ACTA HAEMATOLOGICA
    
    I. Gouin-Thibault et al., "The thrombophilic state in cancer patients", ACT HAEMAT, 106(1-2), 2001, pp. 33-42
29. Spina, V; Aleandri, V; Morini, F
    The impact of the Factor V Leiden mutation on pregnancy
    HUMAN REPRODUCTION UPDATE
    
    V. Spina et al., "The impact of the Factor V Leiden mutation on pregnancy", HUM REP UPD, 6(3), 2000, pp. 301-306
30. Murphy, RP; Donoghue, C; Nallen, RJ; D'Mello, M; Regan, C; Whitehead, AS; Fitzgerald, DJ
    Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    R.P. Murphy et al., "Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy", ART THROM V, 20(1), 2000, pp. 266-270
31. Sartori, MT; Simioni, P; Patrassi, GM; Theodoridis, P; Tormene, D; Girolami, A
    Combined heterozygous plasminogen deficiency and factor V Leiden defect inthe same kindred
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    
    M.T. Sartori et al., "Combined heterozygous plasminogen deficiency and factor V Leiden defect inthe same kindred", CL APPL T-H, 6(1), 2000, pp. 36-40
32. Bank, I; Middeldorp, S; Buller, HR
    Hereditary and acquired thrombophilia
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    
    I. Bank et al., "Hereditary and acquired thrombophilia", SEM RESP CR, 21(6), 2000, pp. 483-491
33. Pecheniuk, NM; Walsh, TP; Marsh, NA
    DNA technology for the detection of common genetic variants that predispose to thrombophilia
    BLOOD COAGULATION & FIBRINOLYSIS
    
    N.M. Pecheniuk et al., "DNA technology for the detection of common genetic variants that predispose to thrombophilia", BL COAG FIB, 11(8), 2000, pp. 683-700
34. Aillaud, MF; Morange, P; Juhan, I; Bauters, A; Jude, B; Biron-Andreani, C; Daures, JP; Schved, JF; Pernod, G; Polac, B; Bridey, F; De Prost, D; Borg, JY; Saladin-Theron, C; Le Cam, V; Denninger, MH; Truchaud, F; Trossaert, M; Boinot, C; Sultan, Y; Delahousse, B; Fimbel, B; Gruel, Y; Houbouyan, L; Bihour, C; Vergnes, C; Dutrillaux, F; Lorenzini, JL; Julia, A; Deschamps, A; Favier, R; Freyburger, G; Trzeciak, MC; Berruyer, M; Doumergue, G; Gris, JC; Toulon, P; Montpied, G; Marques-Verdier, A; Lequerrec, A; Guerin, V; Massignon, D
    Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study
    BLOOD COAGULATION & FIBRINOLYSIS
    
    M.F. Aillaud et al., "Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study", BL COAG FIB, 11(6), 2000, pp. 511-518
35. Pecheniuk, NM; Marsh, NA; Walsh, TP
    Multiple analysis of three common genetic alterations associated with thrombophilia
    BLOOD COAGULATION & FIBRINOLYSIS
    
    N.M. Pecheniuk et al., "Multiple analysis of three common genetic alterations associated with thrombophilia", BL COAG FIB, 11(2), 2000, pp. 183-189
36. Yetkin, E; Erbay, AR; Ayaz, S; Ileri, M; Yanik, A; Yetkin, G; Cehreli, S; Goksel, S
    Predictors of left ventricular thrombus formation in patients with anterior myocardial infarction: role of activated protein C resistance
    CORONARY ARTERY DISEASE
    
    E. Yetkin et al., "Predictors of left ventricular thrombus formation in patients with anterior myocardial infarction: role of activated protein C resistance", CORON ART D, 11(3), 2000, pp. 269-272
37. Mohanty, S; Saxena, R; Acharya, SK
    Activated protein C resistance in Budd-Chiari syndrome
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    S. Mohanty et al., "Activated protein C resistance in Budd-Chiari syndrome", INT J HEMAT, 72(2), 2000, pp. 255-255
38. Makris, TK; Krespi, PG; Hatzizacharias, AN; Gialeraki, AE; Anastasiadis, G; Triposkiadis, FK; Mandalaki, T; Kyriakidis, MK
    Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension
    AMERICAN JOURNAL OF HYPERTENSION
    
    T.K. Makris et al., "Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension", AM J HYPERT, 13(1), 2000, pp. 61-65
39. Deitcher, SR; Caiola, E; Jaffer, A
    Factor V Leiden and prothrombin G20210A - Demystifying two common genetic predispositions to venous thrombosis
    CLEVELAND CLINIC JOURNAL OF MEDICINE
    
    S.R. Deitcher et al., "Factor V Leiden and prothrombin G20210A - Demystifying two common genetic predispositions to venous thrombosis", CLEV CLIN J, 67(11), 2000, pp. 825
40. Hingorani, A; Ascher, E; Yorkavich, W; Mazzariol, F; Jacob, T; Gunduz, Y; Salles-Cunha, S
    Upper extremity deep venous thrombosis: An underrecognized manifestation of a hypercoagulable state
    ANNALS OF VASCULAR SURGERY
    
    A. Hingorani et al., "Upper extremity deep venous thrombosis: An underrecognized manifestation of a hypercoagulable state", ANN VASC S, 14(5), 2000, pp. 421-426
41. Silver, D; Vouyouka, A
    The caput medusae of hypercoagulability
    JOURNAL OF VASCULAR SURGERY
    
    D. Silver e A. Vouyouka, "The caput medusae of hypercoagulability", J VASC SURG, 31(2), 2000, pp. 396-405
42. Ioannou, HV; Mitsis, M; Eleftheriou, A; Matsagas, M; Nousias, V; Rigopoulos, C; Vartholomatos, G; Kappas, AM
    The prevalence of Factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece
    INTERNATIONAL ANGIOLOGY
    
    H.V. Ioannou et al., "The prevalence of Factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece", INT ANGIOL, 19(4), 2000, pp. 314-318
43. van Aken, BE; den Heijer, M; Bos, GMJ; van Deventer, SJH; Reitsma, PH
    Recurrent venous thrombosis and markers of inflammation
    THROMBOSIS AND HAEMOSTASIS
    
    B.E. van Aken et al., "Recurrent venous thrombosis and markers of inflammation", THROMB HAEM, 83(4), 2000, pp. 536-539
44. de Visser, MCH; Guasch, JF; Kamphuisen, PW; Vos, HL; Rosendaal, FR; Bertina, RM
    The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis
    THROMBOSIS AND HAEMOSTASIS
    
    M.C.H. de Visser et al., "The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis", THROMB HAEM, 83(4), 2000, pp. 577-582
45. Luddington, R; Jackson, A; Pannerselvam, S; Brown, K; Baglin, T
    The factor V R2 allele: Risk of venous thromboembolism, factor V levels and resistance to activated protein C
    THROMBOSIS AND HAEMOSTASIS
    
    R. Luddington et al., "The factor V R2 allele: Risk of venous thromboembolism, factor V levels and resistance to activated protein C", THROMB HAEM, 83(2), 2000, pp. 204-208
46. Kraus, JA; Stuper, BK; Nahser, HC; Klockgether, T; Berlit, P
    Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas
    JOURNAL OF NEUROLOGY
    
    J.A. Kraus et al., "Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas", J NEUROL, 247(7), 2000, pp. 521-523
47. Marz, W; Nauck, M; Wieland, H
    The molecular mechanisms of inherited thrombophilia
    ZEITSCHRIFT FUR KARDIOLOGIE
    
    W. Marz et al., "The molecular mechanisms of inherited thrombophilia", Z KARDIOL, 89(7), 2000, pp. 575-586
48. Pirisi-Hauck, NC; Foss, HD; Baier, J; Kurunczi, S
    Simultaneous occurrence of autoimmune enteropathy and recurrent deep venous thrombosis
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    
    N.C. Pirisi-Hauck et al., "Simultaneous occurrence of autoimmune enteropathy and recurrent deep venous thrombosis", J PED GASTR, 30(3), 2000, pp. 324-329
49. Garcia-Doval, I; Losada, A; de la Torre, C; Gonzalez, A; Cruces, MJ
    Abdominal nodules as a presentation of obstruction of the inferior vena cava and factor V Leiden mutation
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    
    I. Garcia-Doval et al., "Abdominal nodules as a presentation of obstruction of the inferior vena cava and factor V Leiden mutation", J AM ACAD D, 42(5), 2000, pp. 862-864
50. Dahlback, B
    Blood coagulation
    LANCET
    
    B. Dahlback, "Blood coagulation", LANCET, 355(9215), 2000, pp. 1627-1632
51. Arkel, YS
    Thrombosis and cancer
    SEMINARS IN ONCOLOGY
    
    Y.S. Arkel, "Thrombosis and cancer", SEMIN ONCOL, 27(3), 2000, pp. 362-374
52. Kostka, H; Siegert, G; Schwarz, T; Gehrisch, S; Kuhlisch, E; Schellong, S; Jaross, W
    Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patients
    THROMBOSIS RESEARCH
    
    H. Kostka et al., "Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patients", THROMB RES, 99(6), 2000, pp. 539-547
53. Larsen, TB; Norgaard-Pedersen, B; Lundemose, JB; Rudiger, N; Gaustadnes, M; Brandslund, I
    Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis
    THROMBOSIS RESEARCH
    
    T.B. Larsen et al., "Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis", THROMB RES, 98(4), 2000, pp. 233-239
54. Manucci, PM
    The molecular basis of inherited thrombophilia
    VOX SANGUINIS
    
    P.M. Manucci, "The molecular basis of inherited thrombophilia", VOX SANGUIN, 78, 2000, pp. 39-45
55. Ekberg, H; Svensson, PJ; Simanaitis, M; Dahlback, B
    Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection
    TRANSPLANTATION
    
    H. Ekberg et al., "Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection", TRANSPLANT, 69(8), 2000, pp. 1577-1581
56. Gherman, RB; Goodwin, TM
    Obstetric implications of activated protein C resistance and factor V leiden Mutation
    OBSTETRICAL & GYNECOLOGICAL SURVEY
    
    R.B. Gherman e T.M. Goodwin, "Obstetric implications of activated protein C resistance and factor V leiden Mutation", OB GYN SURV, 55(2), 2000, pp. 117-122
57. Weih, M; Junge-Hulsing, J; Mehraein, S; Ziemer, S; Einhaupl, KM
    Hereditary thrombophilias in ischemic stroke and sinus vein thrombosis: diagnostic, therapy and meta-analysis
    NERVENARZT
    
    M. Weih et al., "Hereditary thrombophilias in ischemic stroke and sinus vein thrombosis: diagnostic, therapy and meta-analysis", NERVENARZT, 71(12), 2000, pp. 936-945
58. Walker, ID
    Thrombophilia in pregnancy
    JOURNAL OF CLINICAL PATHOLOGY
    
    I.D. Walker, "Thrombophilia in pregnancy", J CLIN PATH, 53(8), 2000, pp. 573-580
59. Martinelli, I; Bucciarelli, P; Margaglione, M; De Stefano, V; Castaman, G; Mannucci, PM
    The risk of venous thromboembolism in family members with mutations in thegenes of factor V or prothrombin or both
    BRITISH JOURNAL OF HAEMATOLOGY
    
    I. Martinelli et al., "The risk of venous thromboembolism in family members with mutations in thegenes of factor V or prothrombin or both", BR J HAEM, 111(4), 2000, pp. 1223-1229
60. Franco, RF; Middeldorp, S; Meinardi, JR; van Pampus, ECM; Reitsma, PH
    Factor XIII Va134Leu and the risk of venous thromboembolism in factor V Leiden carriers
    BRITISH JOURNAL OF HAEMATOLOGY
    
    R.F. Franco et al., "Factor XIII Va134Leu and the risk of venous thromboembolism in factor V Leiden carriers", BR J HAEM, 111(1), 2000, pp. 118-121
61. Mitsis, M; Ioannou, H; Eleftheriou, A; Nousias, V; Basioukas, C; Kakosimos, G; Batsis, C; Vartholomatos, G
    Combined genetic defect (homogeneity for factor V Leiden and heterogeneityfor prothrombin G20210A allele), in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome - A case report
    ANGIOLOGY
    
    M. Mitsis et al., "Combined genetic defect (homogeneity for factor V Leiden and heterogeneityfor prothrombin G20210A allele), in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome - A case report", ANGIOLOGY, 51(4), 2000, pp. 325-329
62. Hisar, I; Ileri, M; Yetkin, E; Atak, R; Senen, K; Kosar, F; Dundar, S; Demirkan, D
    Role of activated protein C resistance in left atrial thrombogenesis in patients with mitral stenosis
    ANGIOLOGY
    
    I. Hisar et al., "Role of activated protein C resistance in left atrial thrombogenesis in patients with mitral stenosis", ANGIOLOGY, 51(10), 2000, pp. 855-860
63. Major, DA; Sane, DC; Herrington, DM
    Cardiovascular implications of the factor V Leiden mutation
    AMERICAN HEART JOURNAL
    
    D.A. Major et al., "Cardiovascular implications of the factor V Leiden mutation", AM HEART J, 140(2), 2000, pp. 189-195
64. Schramm, W; Heinemann, LA; Spannagl, M; Dick, A; Assmann, A
    The Bavarian thromboembolie risk cohort study(BATER)
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    W. Schramm et al., "The Bavarian thromboembolie risk cohort study(BATER)", DEUT MED WO, 125(1-2), 2000, pp. 2-6
65. Simioni, P
    The molecular genetics of familial venous thrombosis
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    P. Simioni, "The molecular genetics of familial venous thrombosis", BEST P R C, 12(3), 1999, pp. 479-503
66. Bucciarelli, P; Rosendaal, FR; Tripodi, A; Mannucci, PM; De Stefano, V; Palareti, G; Finazzi, G; Baudo, F; Quintavalla, R
    Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    P. Bucciarelli et al., "Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study", ART THROM V, 19(4), 1999, pp. 1026-1033
67. Ehrenforth, S; Prondsinski, MV; Aygoren-Pursun, E; Scharrer, I; Ganser, A
    Study of the prothrombin gene 20201 GA variant in FV : Q(506) carriers in relationship to the presence or absence of juvenile venous thromboembolism
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    S. Ehrenforth et al., "Study of the prothrombin gene 20201 GA variant in FV : Q(506) carriers in relationship to the presence or absence of juvenile venous thromboembolism", ART THROM V, 19(2), 1999, pp. 276-280
68. Junker, R; Koch, HG; Auberger, K; Munchow, N; Ehrenforth, S; Nowak-Gottl, U
    Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    R. Junker et al., "Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia", ART THROM V, 19(10), 1999, pp. 2568-2572
69. Favaloro, EJ; Mirochnik, O; McDonald, D
    Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT- than APTT-based assays
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE
    
    E.J. Favaloro et al., "Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT- than APTT-based assays", BR J BIOMED, 56(1), 1999, pp. 23-33
70. Provan, D; O'Shaughnessy, DF
    Recent advances in haematology
    BRITISH MEDICAL JOURNAL
    
    D. Provan e D.F. O'Shaughnessy, "Recent advances in haematology", BR MED J, 318(7189), 1999, pp. 991-994
71. Mammo, L; Saour, JN
    Lack of association between factor V Leiden and thromboembolism in patients with prosthetic heart valves
    BLOOD COAGULATION & FIBRINOLYSIS
    
    L. Mammo e J.N. Saour, "Lack of association between factor V Leiden and thromboembolism in patients with prosthetic heart valves", BL COAG FIB, 10(3), 1999, pp. 141-144
72. Suzuki, S; Kobayashi, H; Matsuo, T
    Activated protein C ratio as a clue for protein S disorder in Japanese
    BLOOD COAGULATION & FIBRINOLYSIS
    
    S. Suzuki et al., "Activated protein C ratio as a clue for protein S disorder in Japanese", BL COAG FIB, 10(3), 1999, pp. 153-154
73. de Ronde, H; Bertina, RM
    Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation
    BLOOD COAGULATION & FIBRINOLYSIS
    
    H. de Ronde e R.M. Bertina, "Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation", BL COAG FIB, 10(1), 1999, pp. 7-17
74. Hansson, PO; Eriksson, E; Welin, L; Eriksson, H
    Prevalence of APC resistance and its relationship to arterial and venous thromboembolism in a general population sample of elderly Swedish men: The Study of Men Born in 1913
    JOURNAL OF INTERNAL MEDICINE
    
    P.O. Hansson et al., "Prevalence of APC resistance and its relationship to arterial and venous thromboembolism in a general population sample of elderly Swedish men: The Study of Men Born in 1913", J INTERN M, 245(6), 1999, pp. 593-600
75. Faude, S; Faude, F; Siegemund, A; Wiedemann, P
    Activated protein C resistance in patients with central retinal vein occlusion in comparison to patients with a history of deep-vein thrombosis and ahealthy control group
    OPHTHALMOLOGE
    
    S. Faude et al., "Activated protein C resistance in patients with central retinal vein occlusion in comparison to patients with a history of deep-vein thrombosis and ahealthy control group", OPHTHALMOLO, 96(9), 1999, pp. 594-599
76. Loew, A; Riess, H
    Clinical importance and evidence of APC-resistance
    PHLEBOLOGIE
    
    A. Loew e H. Riess, "Clinical importance and evidence of APC-resistance", PHLEBOLOGIE, 28(3), 1999, pp. 74-80
77. Grohmann, G; Sigusch, HH; Reinhardt, D; Pohlmann, G; Hoffman, A; Figulla, HR
    Genetic risk factors for phlebothrombosis: New aspects under special consideration of the inherited resistance to activated protein C (coagulation factor V Leiden).
    PERFUSION
    
    G. Grohmann et al., "Genetic risk factors for phlebothrombosis: New aspects under special consideration of the inherited resistance to activated protein C (coagulation factor V Leiden).", PERFUSION, 12(7), 1999, pp. 271
78. Spencer, FA; Becker, RC
    Diagnosis and management of inherited and acquired thrombophilias
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    F.A. Spencer e R.C. Becker, "Diagnosis and management of inherited and acquired thrombophilias", J THROMB TH, 7(2), 1999, pp. 91-104
79. Koren, A; Zalman, L; Levin, C; Abu Hana, M; Mader, R; Shalev, S
    Venous thromboembolism, factor V Leiden, and methylenetetrahydrofolate reductase in a sickle cell anemia patient
    PEDIATRIC HEMATOLOGY AND ONCOLOGY
    
    A. Koren et al., "Venous thromboembolism, factor V Leiden, and methylenetetrahydrofolate reductase in a sickle cell anemia patient", PED HEM ONC, 16(5), 1999, pp. 469-472
80. Tirado, I; Mateo, J; Oliver, A; Borrell, M; Souto, JC; Fontcuberta, J
    Patients with venous thromboembolism have a lower APC response than controls. Should this be regarded as a continuous risk factor for venous thrombosis?
    HAEMATOLOGICA
    
    I. Tirado et al., "Patients with venous thromboembolism have a lower APC response than controls. Should this be regarded as a continuous risk factor for venous thrombosis?", HAEMATOLOG, 84(5), 1999, pp. 470-472
81. Zoller, B; de Frutos, PG; Hillarp, A; Dahlback, B
    Thrombophilia as a multigenic disease
    HAEMATOLOGICA
    
    B. Zoller et al., "Thrombophilia as a multigenic disease", HAEMATOLOG, 84(1), 1999, pp. 59-70
82. Kuismanen, K; Savontaus, ML; Kozlov, A; Vuorio, AF; Sajantila, A
    Coagulation factor V Leiden mutation in sudden fatal pulmonary embolism and in a general northern European population sample
    FORENSIC SCIENCE INTERNATIONAL
    
    K. Kuismanen et al., "Coagulation factor V Leiden mutation in sudden fatal pulmonary embolism and in a general northern European population sample", FOREN SCI I, 106(2), 1999, pp. 71-75
83. Happich, D; Schwaab, R; Hanfland, P; Hoernschemeyer, D
    Allelic discrimination of factor V Leiden using a 5 ' nuclease assay
    THROMBOSIS AND HAEMOSTASIS
    
    D. Happich et al., "Allelic discrimination of factor V Leiden using a 5 ' nuclease assay", THROMB HAEM, 82(4), 1999, pp. 1294-1296
84. Bertina, RM
    Molecular risk factors for thrombosis
    THROMBOSIS AND HAEMOSTASIS
    
    R.M. Bertina, "Molecular risk factors for thrombosis", THROMB HAEM, 82(2), 1999, pp. 601-609
85. Rosendaal, FR
    Risk factors for venous thrombotic disease
    THROMBOSIS AND HAEMOSTASIS
    
    F.R. Rosendaal, "Risk factors for venous thrombotic disease", THROMB HAEM, 82(2), 1999, pp. 610-619
86. Lindmarker, P; Schulman, S; Sten-Linder, M; Wiman, B; Egberg, N; Johnsson, H
    The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene
    THROMBOSIS AND HAEMOSTASIS
    
    P. Lindmarker et al., "The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene", THROMB HAEM, 81(5), 1999, pp. 684-689
87. McColl, MD; Chalmers, EA; Thomas, A; Sproul, A; Healey, C; Rafferty, I; McWilliam, R; Eunson, P
    Factor V Leiden, prothrombin 20210 G -> A and the MTHFR C677T mutations inchildhood stroke
    THROMBOSIS AND HAEMOSTASIS
    
    M.D. McColl et al., "Factor V Leiden, prothrombin 20210 G -> A and the MTHFR C677T mutations inchildhood stroke", THROMB HAEM, 81(5), 1999, pp. 690-694
88. Mohanty, S; Saxena, R; Behari, M
    Activated protein C (APC) resistance in young stroke patients
    THROMBOSIS AND HAEMOSTASIS
    
    S. Mohanty et al., "Activated protein C (APC) resistance in young stroke patients", THROMB HAEM, 81(3), 1999, pp. 465-466
89. Alhenc-Gelas, M; Nicaud, V; Gandrille, S; van Dreden, P; Amiral, J; Aubry, ML; Fiessinger, JN; Emmerich, J; Aiach, M
    The factor V gene A4070G mutation and the risk of venous thrombosis
    THROMBOSIS AND HAEMOSTASIS
    
    M. Alhenc-Gelas et al., "The factor V gene A4070G mutation and the risk of venous thrombosis", THROMB HAEM, 81(2), 1999, pp. 193-197
90. Simioni, P; Sanson, BJ; Prandoni, P; Tormene, D; Friederich, PW; Girolami, B; Gavasso, S; Huisman, MV; Buller, HR; ten Cate, JW; Girolami, A; Prins, MH
    Incidence of venous thromboembolism in families with inherited thrombophilia
    THROMBOSIS AND HAEMOSTASIS
    
    P. Simioni et al., "Incidence of venous thromboembolism in families with inherited thrombophilia", THROMB HAEM, 81(2), 1999, pp. 198-202
91. Witham, TF; Nemoto, EM; Jungreis, CA; Kaufmann, AM
    Near-infrared spectroscopy monitored cerebral venous thrombolysis
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    
    T.F. Witham et al., "Near-infrared spectroscopy monitored cerebral venous thrombolysis", CAN J NEUR, 26(1), 1999, pp. 48-52
92. Pablos, JL; Caliz, RA; Carreira, PE; Atsumi, T; Serrano, L; Amengual, O; Santiago, B; Khamashta, MA; Hughes, GRV; Gomez-Reino, JJ
    Risk of thrombosis in patients with antiphospholipid antibodies and factorV Leiden mutation
    JOURNAL OF RHEUMATOLOGY
    
    J.L. Pablos et al., "Risk of thrombosis in patients with antiphospholipid antibodies and factorV Leiden mutation", J RHEUMATOL, 26(3), 1999, pp. 588-590
93. Samama, MM; Gerotziafas, G; Conrad, J; Horellou, MH; Elalamy, I
    Clinical aspects and laboratory problems in hereditary thrombophilia
    HAEMOSTASIS
    
    M.M. Samama et al., "Clinical aspects and laboratory problems in hereditary thrombophilia", HAEMOSTASIS, 29(2-3), 1999, pp. 76-99
94. Rosendaal, FR
    Venous thrombosis: Prevalence and interaction of risk factors
    HAEMOSTASIS
    
    F.R. Rosendaal, "Venous thrombosis: Prevalence and interaction of risk factors", HAEMOSTASIS, 29, 1999, pp. 1-9
95. Coumans, ABC; Huijgens, PC; Jakobs, C; Schats, R; de Vries, JIP; van Pampus, MG; Dekker, GA
    Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion
    HUMAN REPRODUCTION
    
    A.B.C. Coumans et al., "Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion", HUM REPR, 14(1), 1999, pp. 211-214
96. Rosing, J; Middeldorp, S; Curvers, J; Thomassen, MCLGD; Nicolaes, GAF; Meijers, JCM; Bouma, BN; Buller, HR; Prins, MH; Tans, G
    Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study
    LANCET
    
    J. Rosing et al., "Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study", LANCET, 354(9195), 1999, pp. 2036-2040
97. Rasendaal, FR
    Venous thrombosis: a multicausal disease
    LANCET
    
    F.R. Rasendaal, "Venous thrombosis: a multicausal disease", LANCET, 353(9159), 1999, pp. 1167-1173
98. Sugimura, M; Kobayashi, T; Kanayama, N; Terao, T
    Detection of decreased response to activated protein C during pregnancy byan endogenous thrombin potential-based assay
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    M. Sugimura et al., "Detection of decreased response to activated protein C during pregnancy byan endogenous thrombin potential-based assay", SEM THROMB, 25(5), 1999, pp. 497-502
99. Baker, WF; Bick, RL
    Treatment of hereditary and acquired thrombophilic disorders
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    W.F. Baker e R.L. Bick, "Treatment of hereditary and acquired thrombophilic disorders", SEM THROMB, 25(4), 1999, pp. 387-406
100. Dahlback, B
     Activated protein C resistance and thrombosis: Molecular mechanisms of hypercoagulable state due to FVR506Q mutation
     SEMINARS IN THROMBOSIS AND HEMOSTASIS
     
     B. Dahlback, "Activated protein C resistance and thrombosis: Molecular mechanisms of hypercoagulable state due to FVR506Q mutation", SEM THROMB, 25(3), 1999, pp. 273-289